<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref37">
 <mixed-citation publication-type="journal" id="cit37">
  <name>
   <surname>Ho</surname>
   <given-names>T. Y.</given-names>
  </name>; 
  <name>
   <surname>Wu</surname>
   <given-names>S. L.</given-names>
  </name>; 
  <name>
   <surname>Chen</surname>
   <given-names>J. C.</given-names>
  </name>; 
  <name>
   <surname>Wei</surname>
   <given-names>Y. C.</given-names>
  </name>; 
  <name>
   <surname>Cheng</surname>
   <given-names>S. E.</given-names>
  </name>; 
  <name>
   <surname>Chang</surname>
   <given-names>Y. H.</given-names>
  </name>; 
  <name>
   <surname>Liu</surname>
   <given-names>H. J.</given-names>
  </name>; 
  <name>
   <surname>Hsiang</surname>
   <given-names>C. Y.</given-names>
  </name>
  <article-title>Design and biological activities of novel inhibitory peptides for SARS-CoV spike protein and angiotensin-converting enzyme 2 interaction</article-title>. 
  <source>Antiviral Res.</source>
  <year>2006</year>, 
  <volume>69</volume>, 
  <fpage>70</fpage>â€“
  <lpage>76</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2005.10.005</pub-id>.
  <pub-id pub-id-type="pmid">16337697</pub-id>
 </mixed-citation>
</ref>
